Skip to main content
CHSCP logo

CHSCP · Chs Inc

Track CHSCP — free
$26.74 +0.07 (+0.26%)

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$26.67 Open$26.69 Day$26.66–26.69 52W close$26.56–30.40 Avg vol 30d15K Short int8K · 1.0d Short vol26% DataJan 2020–Sep 2026 Filing10-Q · Jul 8

Up next

filed Jul 8, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Poor Quant / Vol Very Low
Market backdrop VIX 15.2 · calm Equity put/call 0.56
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −3%
below
Price vs 50-day avg −0%
below
RSI (14) 49
neutral
MACD trend Positive
52-week position 3%
near low
Momentum
relative strength
Very Weak
1-month return 0%
trailing
6-month return −6%
trailing
YTD return −4%
this year
Relative strength −21%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $27 › 200d $28 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
▼ -51.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
2 holders — near 3-yr low, contrarian setup
Fundamentals
Poor
Revenue growth −10%
Y/Y
Gross margin 3%
contracting
Free cash flow $-92.8M
Balance sheet $1.5B
net debt
Quant / Vol
risk profile
Very Low
Volatility 9%
annualized · 1-yr
Max drawdown −13%
past year
ATR 0.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−3% Neutral
Price vs 50-day avg
−0% Neutral
RSI (14)
49 Neutral
MACD trend
Positive Bullish
52-week position
3% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $27 › 200d $28 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
▼ -51.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
2 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $27 Now $27 · 3% Range high $30
vs 200-day avg -3% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Farm Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CHSCP
Chs Inc
this stock
-3.7% -9.7%
ADM
Archer-Daniels-Midland Co
$41.15B +48.5% -6.2% 23.3 2.5%
BG
Bunge Global SA
$23.84B +37.9% +32.4% 28.6 3.2%
TSN
Tyson Foods, Inc.
$19.81B -4.8% +2.1% 34.8 2.1%
CALM
Cal-Maine Foods Inc
$3.70B -0.9% -31.7% 10.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
2
Net QoQ
-26.8K sh
Top holder
IMA Advisory Services, In…
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Falling
Shares short
8.3K
Days to cover
1.0d
Change
-8.8K sh
View
Short Volume
Short vol %
26%
As of
Sep 3, 2026
Short Total
View
Fails to Deliver
FTD shares
44
Value
$1.2K
As of
Aug 11, 2026
View
Off-Exchange
Off-exchange %
39.3%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$35.5B
Net income (FY)
$597.9M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 26, 2026
This year
12
View

Performance

5D 20D 120D MTD YTD
CHSCP +0.0% -0.2% -6.4% -0.1% -3.7%
SPY -0.1% -0.6% +14.9% -0.3% +12.2%
vs SPY +0.1% +0.4% -21.3% +0.2% -15.9%

Capital returns

Latest dividend
$0.50 / share · ex Jun 15, 2026
Declared · upcoming
$0.50 / share · ex Sep 16, 2026
Paid (TTM)
$2.00 / share · 4 payouts
Dividend yield (TTM, derived)
7.50%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 823277 CUSIP 12542R209 13F (30d) 1 filings 1 filers Visit website Investor relations